argenx SE Stock News

Rubius Therapeutics (NASDAQ:RUBY) and argenx (NASDAQ:ARGX) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommen

Bank of New York Mellon Corp raised its stake in argenx SE – (NASDAQ:ARGX) by 36.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The insti

Equities research analysts expect that argenx SE – (NASDAQ:ARGX) will announce sales of $17.21 million for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for a

Arden Trust Co purchased a new position in argenx SE – (NASDAQ:ARGX) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchas

argenx SE – (NASDAQ:ARGX) was the target of a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 917,900 shares, a drop of 12.1% from the March

Bank of America Corp DE lifted its stake in argenx SE – (NASDAQ:ARGX) by 302.9% in the 4th quarter, HoldingsChannel reports. The firm owned 25,055 shares of the company’s stock after buying an add

Franklin Resources Inc. grew its holdings in shares of argenx SE – (NASDAQ:ARGX) by 20.1% during the fourth quarter, HoldingsChannel reports. The firm owned 623,968 shares of the company’s stock a

Sutro Biopharma (NASDAQ:STRO) and argenx (NASDAQ:ARGX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability,

Stating the obvious, Baird analysts have created three lists of healthcare companies that may be worth a look considering their attractive valuations or relatively strong capitalizations amid the COVI

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was

Efgartigimod is set to change treatment paradigm in MG indication. Efgartigimod has also demonstrated promising efficacy in additional indications. Collaboratio